On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Hephaistos-Pharma's own share of each project, not the project's full budget.
- Horizon Europe€2.5M · 1 project
- Horizon 2020€50k · 1 project
Projects
2 EU-funded projects, newest first. Hephaistos-Pharma led 2 of them as coordinator. Each links to the official record.
- €2.5Mtheir share
- ONCO-BOOSTCoordinator
Boosting immuno-oncology strategies with innovative immuno-stimulants derived from bacteria, to be administrated in combination with therapeutic monoclonal antibodies
Horizon 2020 · 2019–2019 · Project on CORDIS ↗
€50ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Hephaistos-BelgiumBelgium · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- entrepreneurship
- immunotherapy
- manufacturing engineering
- oncology
- public health
- vaccines
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.